Apolipoprotein E deficiency attenuated osteogenesis via down-regulating osterix

• Published in: Drug Discoveries & Therapeutics Vol. 17; no. 4; pp. 270 - 278
• Main Authors: Qi, Qing, Xu, Yingping, Sun, Hongmei, Zhou, Jing, Li, Lisha, Pan, Xinyao, Wang, Jing, Cao, Wenli, Sun, Yan, Wang, Ling
• Format: Journal Article
• Language: English
• Published: International Research and Cooperation Association for Bio & Socio-Sciences Advancement 31.08.2023
• Subjects: apolipoprotein E; osteoblast; osteogenesis; osterix
• ISSN: 1881-7831; 1881-784X
• DOI: 10.5582/ddt.2023.01026

Apolipoprotein E (ApoE), a ligand for low-density lipoprotein receptors, is strongly induced during osteogenesis and has a physiologic role in regulating osteoblast function, but the mechanisms of its action are still unclear. The study aims to elucidate the influence and molecular mechanisms of ApoE on bone formation. An ovariectomy-induced osteoporotic model were conducted in ApoE knockout (ApoE-/-) mice to study the effect of ApoE on the bone system. Bone quality were assessed through bone mineral density and histomorphometric analysis. To investigate the underlying role and mechanisms of ApoE during osteogenesis, primary osteoblasts from the calvariums of newborn ApoE-/- or wild-type (WT) mice were cultured in the osteoblastic differentiation medium in vitro for further research. Our animal experiment data showed that ApoE-/- mice exhibited bone loss, exacerbated by estrogen deprivation after ovariectomy. ApoE deficiency attenuated osteoblast activity and inhibited osteoblast osteogenesis, accompanied by decreased osterix expression. ApoE deficiency did not affect primary osteoblast viability and collagen-1 expression. Moreover, osteoprotegerin expression in ApoE-/- osteoblasts was reduced compared to WT controls. Our study demonstrated that ApoE gene deficiency contributed to bone loss and attenuated osteogenesis by down-regulating osterix expression.